We are live on ! Find out more
TELO icon

Telomir Pharmaceuticals
TELO

42 hedge funds and large institutions have $11.9M invested in Telomir Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 13 increasing their positions, 14 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 4

8% more funds holding

Funds holding: 39 → 42 (+3)

0.41% more ownership

Funds ownership: 12% → 12.41% (+0.41%)

7% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 14

20% less capital invested

Capital invested by funds: $14.9M → $11.9M (-$2.98M)

Holders
42
Holders Change
+3
Holders Change %
+7.69%
% of All Funds
0.56%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
13
Reduced
14
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$628K
2
HighTower Advisors
HighTower Advisors
Illinois
+$188K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$104K
4
Bank of New York Mellon
Bank of New York Mellon
New York
+$83.3K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$68.1K

Top Sellers

Rank Fund Capital Flow
1
GAM
Gotham Asset Management
New York
-$229K
2
JP Morgan Chase
JP Morgan Chase
New York
-$141K
3
T
Transce3nd
Texas
-$119K
4
Goldman Sachs
Goldman Sachs
New York
-$79.8K
5
VF
Virtu Financial
New York
-$62K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
26
Bank of America
North Carolina
$29.3K -$24.7K -5,649 -38%
PFSRSONJ
27
Police & Firemen's Retirement System of New Jersey
New Jersey
$19.9K +$27K +6,175 New
TRCT
28
Tower Research Capital (TRC)
New York
$8.78K +$1.58K +362 +15%
Legal & General Group
29
Legal & General Group
United Kingdom
$6.27K – – –
California State Teachers Retirement System (CalSTRS)
30
California State Teachers Retirement System (CalSTRS)
California
$4.7K – – –
BNP Paribas Financial Markets
31
BNP Paribas Financial Markets
France
$4.08K -$13.7K -3,143 -71%
Fidelity Investments
32
Fidelity Investments
Massachusetts
$2.64K -$2.52K -576 -41%
AB
33
Amalgamated Bank
New York
$2K +$2.19K +501 +302%
Carson Wealth (CWM LLC)
34
Carson Wealth (CWM LLC)
Nebraska
$2K +$2.49K +569 +569%
Jones Financial Companies
35
Jones Financial Companies
Missouri
$1.73K +$1.91K +438 New
AIP
36
Ameritas Investment Partners
Nebraska
$1.52K – – –
Royal Bank of Canada
37
Royal Bank of Canada
Ontario, Canada
$1K -$3.3K -755 -59%
Nisa Investment Advisors
38
Nisa Investment Advisors
Missouri
$591 +$223 +51 +39%
SCM
39
Sterling Capital Management
North Carolina
$478 -$529 -121 -45%
Russell Investments Group
40
Russell Investments Group
United Kingdom
$336 +$455 +104 New
EWA
41
EverSource Wealth Advisors
Alabama
$284 +$385 +88 New
SS
42
SBI Securities
Japan
$10 – – –
T
43
Transce3nd
Texas
– -$119K -28,803 Closed
VF
44
Virtu Financial
New York
– -$62K -14,959 Closed
BHWM
45
Beaird Harris Wealth Management
Texas
– -$60.2K -14,623 Closed
GAM
46
Gotham Asset Management
New York
– -$229K -6,770 Closed
1
2

TELO Hedge Fund Activity: Q1 2025 in Review

42 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Telomir Pharmaceuticals (TELO) for Q1 2025, worth a combined $11.9M — down 20% from $14.9M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new TELO positions and 4 closed out — a net gain of 3 holders — while 13 added to existing stakes and 14 trimmed.

The largest buyer was BlackRock, adding an estimated $628K. The largest seller was Gotham Asset Management, exiting entirely with an estimated $229K sold.

  • 42 institutional investors held Telomir Pharmaceuticals (TELO) as of Q1 2025, up from 39 in Q4 2024.
  • Funds reported $11.9M of Telomir Pharmaceuticals stock for Q1 2025, down 20% quarter-over-quarter.
  • 7 funds opened new Telomir Pharmaceuticals positions in Q1 2025 and 4 closed out, a net change of +3 holders.
  • The largest Telomir Pharmaceuticals buyer in Q1 2025 was BlackRock, an estimated $628K added.
  • The largest Telomir Pharmaceuticals seller in Q1 2025 was Gotham Asset Management, an estimated $229K sold.

Based on aggregated 13F filings for Q1 2025.